Integral’s Granite-Integral leads Craif Series D with USD 15 million investment

PUBT · 2d ago
Integral’s Granite-Integral leads Craif Series D with USD 15 million investment
  • Integral-backed Granite-Integral led Craif’s Series D round with a USD 15 million investment, disclosed Aug. 18, 2026.
  • Craif develops “MySignal,” a urine-based cancer risk test using AI analysis of microRNA to assess risk for 10 cancers.
  • Granite-Integral plans to support Craif’s distribution in Japan via corporate benefits programs, medical providers, North America, and Asia expansion.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Integral Corporation published the original content used to generate this news brief on August 18, 2026, and is solely responsible for the information contained therein.